Features of changes of system and local level of nitric oxide metabolitesand concentration of soluble molecules of major histocompatibility complex class i at patients with anexacerbation of COPD

S. Soodaeva, N. Kubysheva, I. Klimanov, T. Li, L. Postnikova, K. Rahatbek, V. Novikov, A. Zhogota (Moscow, Nizhny Novgorod, Iowa City, Russian Federation; Mexico, Mexico)

Source: International Congress 2014 – Basic and translational research in asthma and COPD
Session: Basic and translational research in asthma and COPD
Session type: Thematic Poster Session
Number: 3835
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Soodaeva, N. Kubysheva, I. Klimanov, T. Li, L. Postnikova, K. Rahatbek, V. Novikov, A. Zhogota (Moscow, Nizhny Novgorod, Iowa City, Russian Federation; Mexico, Mexico). Features of changes of system and local level of nitric oxide metabolitesand concentration of soluble molecules of major histocompatibility complex class i at patients with anexacerbation of COPD. Eur Respir J 2014; 44: Suppl. 58, 3835

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nitric oxide metabolism in COPD comorbidities
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014

The relationship between the concentration of soluble icam-3 molecules and indicators of nitrosative stress in patients with an exacerbation of COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014

Inducible nitric oxide synthase polymorphism in asthmatic patients
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Association of polymorphisms in renin-angiotensin-aldosterone system pathway, nitric oxide synthase 3 with acute mountain sickness
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


The role of nitric oxide, reactive nitrogen and oxygen species in lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD)
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

Base nitric oxide level in saliva in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 736s
Year: 2005

Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

iNOS expression is increased in peripheral airways of asthmatic patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015

Nitric oxide - a marker of tuberculosis process activity
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017


Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease
Source: International Congress 2016 – Airway biomarkers
Year: 2016


Association between nitric oxide and clinical phenotype in children with CF
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

Human eosinophil toll-like receptor 7-induced nitric oxide is antiviral against parainfluenza
Source: International Congress 2016 – Airway response to infection
Year: 2016

Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Clinical correlates of alveolar nitric oxide in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018